{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:38:31Z","timestamp":1791873511005,"version":"4.3.4"},"reference-count":55,"publisher":"Impact Journals, LLC","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,5,31]]},"DOI":"10.18632\/oncotarget.8924","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T21:14:16Z","timestamp":1461359656000},"page":"33272-33285","source":"Crossref","is-referenced-by-count":18,"title":["The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer"],"prefix":"10.18632","volume":"7","author":[{"given":"Vrajesh","family":"Pandya","sequence":"first","affiliation":[{"name":"Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl","family":"Glubrecht","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Vos","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hanson","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sambasivarao","family":"Damaraju","sequence":"additional","affiliation":[{"name":"Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mackey","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Hugh","sequence":"additional","affiliation":[{"name":"Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ing Swie","family":"Goping","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada"},{"name":"Department of Oncology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,4,22]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Forman","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Bray","year":"2015","journal-title":"International journal of cancer"},{"key":"3","article-title":"Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11","volume":"v10","author":"Bray","year":"2013","journal-title":"GLOBOCAN 2012"},{"key":"4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molonc.2012.01.010","article-title":"Cancer biomarkers","volume":"6","author":"Hayes","year":"2012","journal-title":"Mol Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1200\/JCO.2015.61.1459","article-title":"Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline","volume":"33","author":"Harris","year":"2015","journal-title":"Journal of clinical oncology"},{"key":"6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.cdd.4400998","article-title":"Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins","volume":"9","author":"Strasser","year":"2002","journal-title":"Cell death and differentiation"},{"key":"7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy","volume":"15","author":"Adams","year":"2014","journal-title":"Nature reviews Molecular cell biology"},{"key":"8","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/onc.2009.39","article-title":"BH3-only proteins in apoptosis and beyond: an overview","volume":"27","author":"Chinnadurai","year":"2008","journal-title":"Oncogene"},{"key":"9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4161\/auto.4237","article-title":"BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2\/Bcl-X(L)","volume":"3","author":"Kroemer","year":"2007","journal-title":"Autophagy"},{"key":"10","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1038\/onc.2013.384","article-title":"Estrogen receptor beta upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer","volume":"33","author":"Gustafsson","year":"2014","journal-title":"Oncogene"},{"key":"11","doi-asserted-by":"crossref","first-page":"49795","DOI":"10.1074\/jbc.M309523200","article-title":"FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines","volume":"278","author":"Lam","year":"2003","journal-title":"The Journal of biological chemistry"},{"key":"12","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4049\/jimmunol.173.2.1111","article-title":"The E2F-1 transcription factor promotes caspase-8 and bid expression, and enhances Fas signaling in T cells","volume":"173","author":"Crispe","year":"2004","journal-title":"Journal of immunology"},{"key":"13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3892\/or_00000891","article-title":"AF1q enhancement of gamma irradiation-induced apoptosis by up-regulation of BAD expression via NF-kappaB in human squamous carcinoma A431 cells","volume":"24","author":"Kwok","year":"2010","journal-title":"Oncology reports"},{"key":"14","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/onc.2009.40","article-title":"BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes","volume":"27","author":"Rashmi","year":"2008","journal-title":"Oncogene"},{"key":"15","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/sj.bjc.6605981","article-title":"BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma","volume":"103","author":"Gomez-Bougie","year":"2010","journal-title":"British journal of cancer"},{"key":"16","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1128\/MCB.01383-13","article-title":"Targeting SQSTM1\/p62 Induces Cargo-Loading Failure and Converts Autophagy to Apoptosis via NBK\/Bik","volume":"34","author":"Grant","year":"2014","journal-title":"Molecular and cellular biology"},{"key":"17","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/cdd.2012.21","article-title":"Src tyrosine kinase inhibits apoptosis through the Erk1\/2- dependent degradation of the death accelerator Bik","volume":"19","author":"Gonzalo","year":"2012","journal-title":"Cell death and differentiation"},{"key":"18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-010-0943-7","article-title":"DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer","volume":"127","author":"Godbout","year":"2011","journal-title":"Breast cancer research and treatment"},{"key":"19","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ajpath.2010.11.075","article-title":"Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy","volume":"178","author":"Godbout","year":"2011","journal-title":"The American journal of pathology"},{"key":"20","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/sj.onc.1210783","article-title":"BH3-only protein BIK induces caspase-independent cell death with autophagic features in Bcl-2 null cells","volume":"27","author":"Chinnadurai","year":"2008","journal-title":"Oncogene"},{"key":"21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/emboj.2009.369","article-title":"Antagonism of Beclin 1-dependent autophagy by BCL-2 at the endoplasmic reticulum requires NAF-1","volume":"29","author":"Shore","year":"2010","journal-title":"The EMBO journal"},{"key":"22","article-title":"Breast cancer cell line MDA-MB-231 miRNA profile expression after BIK interference: BIK involvement in autophagy","author":"Velazquez-Flores","year":"2015","journal-title":"Tumour Biol"},{"key":"23","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.cell.2013.11.019","article-title":"Autophagy-mediated tumor promotion","volume":"155","author":"White","year":"2013","journal-title":"Cell"},{"key":"24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1101\/gad.2016111","article-title":"Pancreatic cancers require autophagy for tumor growth","volume":"25","author":"Bardeesy","year":"2011","journal-title":"Genes & development"},{"key":"25","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1101\/gad.2051011","article-title":"Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis","volume":"25","author":"Guan","year":"2011","journal-title":"Genes & development"},{"key":"26","first-page":"5611","article-title":"Immunopositivity of Beclin-1 and ATG5 as indicators of survival and disease recurrence in oral squamous cell carcinoma","volume":"33","author":"Chu","year":"2013","journal-title":"Anticancer research"},{"key":"27","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1600-0463.2011.02812.x","article-title":"Expressional and mutational analyses of ATG5 gene in prostate cancers","volume":"119","author":"Lee","year":"2011","journal-title":"APMIS"},{"key":"28","doi-asserted-by":"crossref","first-page":"e110293","DOI":"10.1371\/journal.pone.0110293","article-title":"Upregulation of autophagy-related gene-5 (ATG-5) is associated with chemoresistance in human gastric cancer","volume":"9","author":"Chen","year":"2014","journal-title":"PloS one"},{"key":"29","first-page":"4091","article-title":"Down-regulated expression of ATG5 in colorectal cancer","volume":"32","author":"Kim","year":"2012","journal-title":"Anticancer research"},{"key":"30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/gcc.10245","article-title":"Mutations of the BIK gene in human peripheral B-cell lymphomas","volume":"38","author":"Larocca","year":"2003","journal-title":"Genes, chromosomes & cancer"},{"key":"31","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1158\/0008-5472.CAN-04-4229","article-title":"High-resolution genome-wide mapping of genetic alterations in human glial brain tumors","volume":"65","author":"Sikic","year":"2005","journal-title":"Cancer research"},{"key":"32","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0016-5085(99)70341-0","article-title":"Mapping of a target region of allelic loss to a 0. 5-cM interval on chromosome 22q13 in human colorectal cancer","volume":"117","author":"Rustgi","year":"1999","journal-title":"Gastroenterology"},{"key":"33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.cdd.4401782","article-title":"Loss of the tissue-specific proapoptotic BH3-only protein Nbk\/Bik is a unifying feature of renal cell carcinoma","volume":"13","author":"Daniel","year":"2006","journal-title":"Cell death and differentiation"},{"key":"34","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1158\/1535-7163.MCT-07-2444","article-title":"Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells","volume":"7","author":"Johnson","year":"2008","journal-title":"Molecular cancer therapeutics"},{"key":"35","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/sj.cgt.7700945","article-title":"Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model","volume":"13","author":"Hung","year":"2006","journal-title":"Cancer gene therapy"},{"key":"36","doi-asserted-by":"crossref","first-page":"e92172","DOI":"10.1371\/journal.pone.0092172","article-title":"BikDDA, a mutant of Bik with longer half-life expression protein, can be a novel therapeutic gene for triple-negative breast cancer","volume":"9","author":"Xie","year":"2014","journal-title":"PloS one"},{"key":"37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10585-007-9083-9","article-title":"Mutant Bik gene transferred by cationic liposome inhibits peritoneal disseminated murine colon cancer","volume":"24","author":"Lan","year":"2007","journal-title":"Clinical & experimental metastasis"},{"key":"38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2407-5-93","article-title":"A molecular analysis by gene expression profiling reveals Bik\/NBK overexpression in sporadic breast tumor samples of Mexican females","volume":"5","author":"Arenas","year":"2005","journal-title":"BMC cancer"},{"key":"39","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s12094-012-0845-8","article-title":"BIK\/NBK gene as potential marker of prognostic and therapeutic target in breast cancer patients","volume":"14","author":"Arenas-Aranda","year":"2012","journal-title":"Clinical & translational oncology"},{"key":"40","doi-asserted-by":"crossref","first-page":"8840","DOI":"10.1038\/ncomms9840","article-title":"Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer","volume":"6","author":"Whitehurst","year":"2015","journal-title":"Nat Commun"},{"key":"41","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","article-title":"The molecular classification of multiple myeloma","volume":"108","author":"Walker","year":"2006","journal-title":"Blood"},{"key":"42","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1371\/journal.pmed.0030467","article-title":"A gene expression signature predicts survival of patients with stage I non-small cell lung cancer","volume":"3","author":"You","year":"2006","journal-title":"PLoS medicine"},{"key":"43","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.molcel.2015.01.018","article-title":"Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death","volume":"57","author":"Oberst","year":"2015","journal-title":"Molecular cell"},{"key":"44","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1093\/annonc\/mdt277","article-title":"Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings","volume":"24","author":"Chan","year":"2013","journal-title":"Annals of oncology"},{"key":"45","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1471-2407-10-186","article-title":"High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology","volume":"10","author":"Syrigos","year":"2010","journal-title":"BMC cancer"},{"key":"46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1008255511404","article-title":"High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia","volume":"9","author":"Bergmann","year":"1998","journal-title":"Annals of oncology"},{"key":"47","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.2005.04.358","article-title":"Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome","volume":"23","author":"Hsi","year":"2005","journal-title":"Journal of clinical oncology"},{"key":"48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.1711770109","article-title":"Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis","volume":"177","author":"Syrjanen","year":"1995","journal-title":"The Journal of pathology"},{"key":"49","first-page":"189","article-title":"Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer","volume":"1","author":"Verderio","year":"1995","journal-title":"Clinical cancer research"},{"key":"50","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2005.07.002","article-title":"Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy","volume":"122","author":"Levine","year":"2005","journal-title":"Cell"},{"key":"51","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.molcel.2008.06.001","article-title":"JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy","volume":"30","author":"Levine","year":"2008","journal-title":"Molecular cell"},{"key":"52","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1084\/jem.183.5.2219","article-title":"Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death","volume":"183","author":"Petrie","year":"1996","journal-title":"The Journal of experimental medicine"},{"key":"53","first-page":"1511","article-title":"Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival","volume":"13","author":"Adams","year":"1996","journal-title":"Oncogene"},{"key":"54","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.prp.2011.05.002","article-title":"Mutational and expressional analyses of ATG5, an autophagy-related gene, in gastrointestinal cancers","volume":"207","author":"Lee","year":"2011","journal-title":"Pathology, research and practice"},{"key":"55","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1038\/onc.2010.272","article-title":"The BH3-only protein Bad confers breast cancer taxane sensitivity through a nonapoptotic mechanism","volume":"29","author":"Goping","year":"2010","journal-title":"Oncogene"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T21:07:46Z","timestamp":1589231266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,22]]},"references-count":55,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2016,5,31]]}},"alternative-id":["8924","27120789"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8924","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,22]]}}}